Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma.
Ontology highlight
ABSTRACT: Malignant pleural mesothelioma (MPM) is a rare malignancy characterized by very poor prognosis and lack of treatment options. Immunotherapy has rapidly emerged as an effective tool for MPM, particularly for tumors of non-epithelioid histology. At the same time, comprehensive genomic sequencing may open the way to new-generation targeted-drugs able to hit specific MPM molecular vulnerabilities. These innovations will possibly enrich, but also dramatically complicate, the elucidation of treatment algorithms. Multidisciplinary integration is urgently needed.
SUBMITTER: Vita E
PROVIDER: S-EPMC8197557 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA